retatrutide triple agonist glp1 gip glucagon The TRIUMPH-1 Phase 3 results just dropped on retatrutide. Here is what the numbers actually say. is a agonist. It targets GLP-1, GIP, and receptors. Ozempic targets one. Mounjaro Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide
Description
Wilmington, DE: AstraZeneca Pharmaceuticals LP;2018
BACKGROUND Heart failure with a preserved ejection fraction (HFpEF) is characterized by frequent hospitalizations, and substantial mortality
Youve got this triple whammy, Musgrave said
The platform provides aggregated data from inpatient and outpatient clinical encounters including demographics, diagnoses, procedures, medications, laboratory tests, and genomic information
Tesamorelin side effects (joint stiffness, mild edema) don't overlap with GLP-1 side effects (nausea, fatigue)
